Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. Its segments include Laboratory Solutions and Bioscience Production. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, and biological safety cabinets. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Employees

14,500

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-10-24 - Q3 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
24-09-17	26.87 $	-1.21%	4,901,690
24-09-16	27.20 $	+1.19%	4,405,415
24-09-13	26.88 $	+1.51%	3,071,432
24-09-12	26.48 $	-1.60%	4,278,089
24-09-11	26.91 $	+1.66%	4,836,560

Delayed Quote Nyse, September 17, 2024 at 04:00 pm EDT

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

26.87USD

Average target price

28.57USD

Spread / Average Target

+6.34%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Nyse Other stock markets 04:00:02 2024-09-17 pm EDT			5-day change	1st Jan Change
26.87 ^USD	-1.21%		+1.51%	+17.70%

Sep. 13	RBC Raises Price Target on Avantor to $34 From $31, Keeps Outperform Rating	MT
Sep. 05	Transcript : Avantor, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM

Capitalization	18.49B	P/E ratio 2024 *	43.6x	P/E ratio 2025 *	29.6x
Enterprise value	20.76B	EV / Sales 2024 *	3.34x	EV / Sales 2025 *	3.08x
Free-Float	96.69%	Yield 2024 *	-	Yield 2025 *	-

RBC Raises Price Target on Avantor to $34 From $31, Keeps Outperform Rating	Sep. 13	MT
Transcript : Avantor, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM	Sep. 05
Wells Fargo Initiates Avantor at Overweight With $30 Price Target	Aug. 28	MT
Avantor to Sell Clinical Services Business to Audax Private Equity	Aug. 16	MT
Avantor to Divest Clinical Services Business to Audax Private Equity for $650 Million	Aug. 16	MT
Audax Management Company, LLC signed a definitive agreement to acquire the Clinical Services Business of Avantor, Inc. in a transaction valued at approximately $650 million.	Aug. 15	CI
Baird Adjusts Price Target on Avantor to $27 From $26, Maintains Outperform Rating	Jul. 29	MT
Sector Update: Health Care Stocks Higher Late Afternoon	Jul. 26	MT
Sector Update: Health Care	Jul. 26	MT
Avantor's Shares Rise After Q2 Adjusted EPS Beat	Jul. 26	MT
Global markets live: Tesla, Take Two, Walt Disney, Colgate, Ford...	Jul. 26
Avantor, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	Jul. 26	CI
Transcript : Avantor, Inc., Q2 2024 Earnings Call, Jul 26, 2024	Jul. 26

RBC Raises Price Target on Avantor to $34 From $31, Keeps Outperform Rating	Sep. 13	MT
Wells Fargo Initiates Avantor at Overweight With $30 Price Target	Aug. 28	MT
Baird Adjusts Price Target on Avantor to $27 From $26, Maintains Outperform Rating	Jul. 29	MT
RBC Lifts Price Target on Avantor to $31 From $30, Keeps Outperform Rating	Jul. 15	MT
Citigroup Downgrades Avantor to Neutral From Buy, Adjusts Price Target to $23 From $30	Jul. 10	MT

Avantor, Inc. Stock

Equities

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Valuation: Avantor, Inc.

Chart: Avantor, Inc.

Latest news: Avantor, Inc.

Last Transcript: Avantor, Inc.

Analysts' recommendations: Avantor, Inc.

Press Releases: Avantor, Inc.

News in other languages: Avantor, Inc.

Quotes and Performance

Managers and Directors: Avantor, Inc.

ETFs: Avantor, Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

Avantor® Achieves Bronze Medal from EcoVadis for Sustainability Performance	Sep. 12	PR
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024	Aug. 23	AQ
Avantor to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference	Aug. 23	AQ
Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference	Aug. 22	PR
Avantor Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private Equity	Aug. 19	AQ

Hermès en cache-misère ?	Jul. 26
En Direct des Marchés : Capgemini et Mercedes avertissent, Hermès et EssilorLuxottica assurent	Jul. 26
Presse: Sartorius und Merck prüfen Übernahme von Single Use Support	Dec. 11
DiaSorin S p A : Schwäbischer Kunststoff-Konzern Ritter für 890 Mio Euro verkauft	21-04-12

Director	Title	Age	Since
Michael Stubblefield CEO	Chief Executive Officer	51	14-04-30
R. Jones DFI	Director of Finance/CFO	54	23-08-06
Claudius Sokenu CMP	Compliance Officer	-	-

Name	Weight	AuM	1st Jan change	Investor Rating
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD	0.80%	7 M€	0.00%
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	0.59%	18 M€	+10.05%	-
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.40%	2 M€	+13.77%

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
AVANTOR, INC.	-1.21%	+5.43%	-	-	18.49B
ABBOTT LABORATORIES	+0.43%	+0.87%	+16.11%	-6.83%	205B
MEDTRONIC PLC	-1.64%	-2.59%	+8.39%	-31.67%	116B
BECTON, DICKINSON AND COMPANY	-1.18%	-1.88%	-12.31%	-11.71%	67.65B
CENCORA, INC.	-2.78%	-1.26%	+31.54%	+89.95%	47.28B
HOYA CORPORATION	+0.45%	+0.82%	+14.65%	+3.26%	47.22B
METTLER-TOLEDO INTERNATIONAL, INC.	-0.70%	-0.76%	+18.38%	-10.47%	29.56B
DEXCOM, INC.	-1.64%	+0.57%	-28.45%	-51.03%	28.09B
TERUMO CORPORATION	+1.29%	+0.92%	+19.08%	-4.11%	27.33B
STERIS PLC	-0.84%	-2.22%	+5.31%	+12.36%	24.04B
Average	-0.78%	+0.83%	+8.08%	-1.14%	60.99B
Weighted average by Cap.	-0.60%	+1.06%	+10.16%	-5.07%

Manager	Title	Age	Since
Michael Stubblefield CEO	Chief Executive Officer	51	14-04-30
Jonathan Peacock CHM	Chairman	66	17-03-31
Juan Andres BRD	Director/Board Member	59	19-08-31

	2024 *	2025 *
Net sales	6.92B	7.27B
Net income	414M	616M
Net Debt	4.64B	3.88B